Figure (Atorvastatin Calcium Figure 1)
Atorvastatin Calcium
Product Images NDC 53002-2335
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Atorvastatin Calcium Figure 2)
This appears to be a graph or chart related to the cumulative hazard of a placebo versus atorvastatin, a drug used to lower cholesterol. The hazard percentage is displayed on the y-axis and the time to the first primary endpoint is shown on the x-axis over a period of four years. The results reveal a significant reduction in hazard for those taking atorvastatin compared to a placebo.*
Figure (Atorvastatin Calcium Figure 3)
This is a statistical data presentation showing the percentage of subjects who experienced an event after taking Atorvastatin 10 mg and 80 mg. The results indicate that the latter was associated with a lower hazard ratio (0.78) and a smaller p-value (0.0002). The graph shows the time in years for the first major cardiovascular endpoint. There is no information to specify the nature of the events or the size and characteristics of the subjects studied.*
Chemical Structure (Atorvastatin Calcium Structure)
Label Image (Lbl530022335)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
